<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04013529</url>
  </required_header>
  <id_info>
    <org_study_id>01758</org_study_id>
    <nct_id>NCT04013529</nct_id>
  </id_info>
  <brief_title>Connected Health to Decrease Opioid Use in Patients With Chronic Pain</brief_title>
  <official_title>Connected Health to Decrease Opioid Use in Patients With Chronic Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this pilot study to evaluate if behavioral incentives applied at the VA&#xD;
      Medical Center can appreciably increase participation in activities that promote mobility,&#xD;
      and subsequently reduce pain severity and opioid use.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Chronic pain is a highly prevalent and costly condition in the US. An estimated 88.5 million&#xD;
      adults suffer from daily pain, resulting in estimated cost of $500- 635 biJlion due to lost&#xD;
      productivity, and $261-300 billion in health care expenditures. To manage their chronic pain,&#xD;
      5 to 8 million Americans take an opioid medication daily. Yet , the risks associated with&#xD;
      ongoing opioid prescription , including overdose, abuse and diversion, temper their analgesic&#xD;
      effects.&#xD;
&#xD;
      Opioids are not more effective in the treatment of chronic pain compared with non-opioid&#xD;
      approaches. Current guidelines have adapted to the evidence, recommending opioid-sparing&#xD;
      approaches for treating patients with chronic pain, and tapering for those on higher doses to&#xD;
      safer levels of use. Tapering opioids, however, requires replacing them with effective&#xD;
      non-opioid strategies. Improving mobility has been shown to improve pain and decrease&#xD;
      medication use among patients chronically prescribed opiates. Concurrently, financial&#xD;
      incentives and the use of behavioral incentives have been shown to promote mobility.&#xD;
&#xD;
      Appreciating the gains in health outcomes that can be made with &quot;connected health&quot;&#xD;
      approaches, we propose a novel pilot study designed to evaluate if technology enabled care&#xD;
      (TEC) strategies and financial incentives can improve patient mobility in our chronic pain&#xD;
      population, reduce pain and decrease opioid use . Our primary aim is to determine if chronic&#xD;
      pain patients who receive TEC-enhanced treatment with financial incentives demonstrate&#xD;
      increased participation in activities that promote mobility (physical therapy, yoga, tai chi)&#xD;
      in comparison to patients receiving usual care. Secondary outcomes will include whether&#xD;
      increased activity participation also reduces pain severity and opioid use, and improves&#xD;
      function and increases the number of daily steps taken. The results of this pilot will enable&#xD;
      us to determine what strategies are effective at increasing mobility and if these gains&#xD;
      translate into reduced pain and decreased opioid use.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 31, 2018</start_date>
  <completion_date type="Actual">September 15, 2020</completion_date>
  <primary_completion_date type="Actual">September 15, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Activity Participation</measure>
    <time_frame>12 weeks</time_frame>
    <description>Stanford Exercise Questionnaire; min score = 0, max score = 180; higher scores = better outcome</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Increased Mobility</measure>
    <time_frame>12 weeks</time_frame>
    <description>steps per day measured by wearable step tracker at 12 weeks</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Daily Opioid Use</measure>
    <time_frame>12 weeks</time_frame>
    <description>measured by opioid morphine mg equivalents used each day (MED)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical Function</measure>
    <time_frame>12 weeks</time_frame>
    <description>measured by interference with walking on PROMIS (Patient-reported Outcomes Measurement Information System) pain interference tool, which is a 6-item self-report survey; each item is scored from 1 (not at all) to 5 (very much), thus scores ranged from 6 to 30, with higher score indicating more pain interference.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Severity</measure>
    <time_frame>12 weeks</time_frame>
    <description>measured by pain severity on PROMIS (Patient-reported Outcomes Measurement Information System) pain severity tool, which is a 3-item self-report survey; each item is scored from 1 (no pain at all) to 5 (very severity), thus scores ranged from 3 to 15, with higher score indicating more severe pain.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participate in technology-enabled care without regret lottery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participate in technology-enabled care with regret lottery</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Regret lottery</intervention_name>
    <description>Subjects who achieve step goals are entered into a lottery in which they can win a financial incentive of $30 or $100.</description>
    <arm_group_label>Experimental</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Way to Health technology enhanced care</intervention_name>
    <description>Subjects receive text reminders to reach activity goals.</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Experimental</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Chronic non-malignant pain&#xD;
&#xD;
          -  High dose opioid therapy&#xD;
&#xD;
          -  Possession of activated cell phone with text messaging capabilities&#xD;
&#xD;
          -  Willingness to comply with study requirements&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pain of malignant origin&#xD;
&#xD;
          -  Sensory impairments precluding use of text messaging and activity tracker&#xD;
&#xD;
          -  Physical disability precluding improvements in physical activity&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Corporal Michael Cresenz VA Medical Center</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>July 2, 2019</study_first_submitted>
  <study_first_submitted_qc>July 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 9, 2019</study_first_posted>
  <results_first_submitted>August 17, 2021</results_first_submitted>
  <results_first_submitted_qc>October 25, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">October 27, 2021</results_first_posted>
  <last_update_submitted>October 25, 2021</last_update_submitted>
  <last_update_submitted_qc>October 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>no plan to share IPD</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 30, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/29/NCT04013529/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Control</title>
          <description>Participate in technology-enabled care without regret lottery&#xD;
Way to Health technology enhanced care: Subjects receive text reminders to reach activity goals.</description>
        </group>
        <group group_id="P2">
          <title>Experimental</title>
          <description>Participate in technology-enabled care with regret lottery&#xD;
Regret lottery: Subjects who achieve step goals are entered into a lottery in which they can win a financial incentive of $30 or $100.&#xD;
Way to Health technology enhanced care: Subjects receive text reminders to reach activity goals.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Control</title>
          <description>Participate in technology-enabled care without regret lottery&#xD;
Way to Health technology enhanced care: Subjects receive text reminders to reach activity goals.</description>
        </group>
        <group group_id="B2">
          <title>Experimental</title>
          <description>Participate in technology-enabled care with regret lottery&#xD;
Regret lottery: Subjects who achieve step goals are entered into a lottery in which they can win a financial incentive of $30 or $100.&#xD;
Way to Health technology enhanced care: Subjects receive text reminders to reach activity goals.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="20"/>
            <count group_id="B3" value="40"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55.2" spread="11.0"/>
                    <measurement group_id="B2" value="59.6" spread="13.5"/>
                    <measurement group_id="B3" value="57.4" spread="12.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="35"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Activity Participation</title>
        <description>Stanford Exercise Questionnaire; min score = 0, max score = 180; higher scores = better outcome</description>
        <time_frame>12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>Participate in technology-enabled care without regret lottery&#xD;
Way to Health technology enhanced care: Subjects receive text reminders to reach activity goals.</description>
          </group>
          <group group_id="O2">
            <title>Experimental</title>
            <description>Participate in technology-enabled care with regret lottery&#xD;
Regret lottery: Subjects who achieve step goals are entered into a lottery in which they can win a financial incentive of $30 or $100.&#xD;
Way to Health technology enhanced care: Subjects receive text reminders to reach activity goals.</description>
          </group>
        </group_list>
        <measure>
          <title>Activity Participation</title>
          <description>Stanford Exercise Questionnaire; min score = 0, max score = 180; higher scores = better outcome</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="156.0" spread="116.8"/>
                    <measurement group_id="O2" value="135.8" spread="123.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>=0.90</p_value>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Increased Mobility</title>
        <description>steps per day measured by wearable step tracker at 12 weeks</description>
        <time_frame>12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>Participate in technology-enabled care without regret lottery&#xD;
Way to Health technology enhanced care: Subjects receive text reminders to reach activity goals.</description>
          </group>
          <group group_id="O2">
            <title>Experimental</title>
            <description>Participate in technology-enabled care with regret lottery&#xD;
Regret lottery: Subjects who achieve step goals are entered into a lottery in which they can win a financial incentive of $30 or $100.&#xD;
Way to Health technology enhanced care: Subjects receive text reminders to reach activity goals.</description>
          </group>
        </group_list>
        <measure>
          <title>Increased Mobility</title>
          <description>steps per day measured by wearable step tracker at 12 weeks</description>
          <units>steps per day</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4313" spread="4231"/>
                    <measurement group_id="O2" value="4075" spread="5598"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>= 0.88</p_value>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Daily Opioid Use</title>
        <description>measured by opioid morphine mg equivalents used each day (MED)</description>
        <time_frame>12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>Participate in technology-enabled care without regret lottery&#xD;
Way to Health technology enhanced care: Subjects receive text reminders to reach activity goals.</description>
          </group>
          <group group_id="O2">
            <title>Experimental</title>
            <description>Participate in technology-enabled care with regret lottery&#xD;
Regret lottery: Subjects who achieve step goals are entered into a lottery in which they can win a financial incentive of $30 or $100.&#xD;
Way to Health technology enhanced care: Subjects receive text reminders to reach activity goals.</description>
          </group>
        </group_list>
        <measure>
          <title>Daily Opioid Use</title>
          <description>measured by opioid morphine mg equivalents used each day (MED)</description>
          <units>morphine mg equivalents per day (MED)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="167.2" spread="244.4"/>
                    <measurement group_id="O2" value="31.9" spread="35.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt; 0.17</p_value>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Physical Function</title>
        <description>measured by interference with walking on PROMIS (Patient-reported Outcomes Measurement Information System) pain interference tool, which is a 6-item self-report survey; each item is scored from 1 (not at all) to 5 (very much), thus scores ranged from 6 to 30, with higher score indicating more pain interference.</description>
        <time_frame>12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>Participate in technology-enabled care without regret lottery&#xD;
Way to Health technology enhanced care: Subjects receive text reminders to reach activity goals.</description>
          </group>
          <group group_id="O2">
            <title>Experimental</title>
            <description>Participate in technology-enabled care with regret lottery&#xD;
Regret lottery: Subjects who achieve step goals are entered into a lottery in which they can win a financial incentive of $30 or $100.&#xD;
Way to Health technology enhanced care: Subjects receive text reminders to reach activity goals.</description>
          </group>
        </group_list>
        <measure>
          <title>Physical Function</title>
          <description>measured by interference with walking on PROMIS (Patient-reported Outcomes Measurement Information System) pain interference tool, which is a 6-item self-report survey; each item is scored from 1 (not at all) to 5 (very much), thus scores ranged from 6 to 30, with higher score indicating more pain interference.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.4" spread="10.94"/>
                    <measurement group_id="O2" value="24.2" spread="12.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt; 0.05</p_value>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Severity</title>
        <description>measured by pain severity on PROMIS (Patient-reported Outcomes Measurement Information System) pain severity tool, which is a 3-item self-report survey; each item is scored from 1 (no pain at all) to 5 (very severity), thus scores ranged from 3 to 15, with higher score indicating more severe pain.</description>
        <time_frame>12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>Participate in technology-enabled care without regret lottery&#xD;
Way to Health technology enhanced care: Subjects receive text reminders to reach activity goals.</description>
          </group>
          <group group_id="O2">
            <title>Experimental</title>
            <description>Participate in technology-enabled care with regret lottery&#xD;
Regret lottery: Subjects who achieve step goals are entered into a lottery in which they can win a financial incentive of $30 or $100.&#xD;
Way to Health technology enhanced care: Subjects receive text reminders to reach activity goals.</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Severity</title>
          <description>measured by pain severity on PROMIS (Patient-reported Outcomes Measurement Information System) pain severity tool, which is a 3-item self-report survey; each item is scored from 1 (no pain at all) to 5 (very severity), thus scores ranged from 3 to 15, with higher score indicating more severe pain.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.7" spread="1.63"/>
                    <measurement group_id="O2" value="6.8" spread="1.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>= 0.81</p_value>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>12 weeks</time_frame>
      <desc>Although considered a minimal risk study, all participants were monitored for adverse events on a weekly basis.</desc>
      <group_list>
        <group group_id="E1">
          <title>Control</title>
          <description>Participate in technology-enabled care without regret lottery&#xD;
Way to Health technology enhanced care: Subjects receive text reminders to reach activity goals.</description>
        </group>
        <group group_id="E2">
          <title>Experimental</title>
          <description>Participate in technology-enabled care with regret lottery&#xD;
Regret lottery: Subjects who achieve step goals are entered into a lottery in which they can win a financial incentive of $30 or $100.&#xD;
Way to Health technology enhanced care: Subjects receive text reminders to reach activity goals.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="19"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Although subjects were blinded to group assignment, it is possible that those in the intervention arm communicated their potential to receive payment to those in the control arm who did not have the same benefit, which may have served as a disincentive for controls to engage in physical activity. Also, subjects in both groups received large numbers of text messages over the study period and may have found the messaging burdensome and thus stopped reading or responding to them as anticipated.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Manik Chhabra</name_or_title>
      <organization>Corporal Michael J. Crescenz VA Medical Center</organization>
      <phone>(215) 823-5800</phone>
      <email>manik.chhabra@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

